These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17376695)

  • 21. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.
    Jarkas N; Voll RJ; Williams L; Votaw JR; Owens M; Goodman MM
    J Med Chem; 2008 Jan; 51(2):271-81. PubMed ID: 18085744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.
    Plisson C; Stehouwer JS; Voll RJ; Howell L; Votaw JR; Owens MJ; Goodman MM
    J Med Chem; 2007 Sep; 50(19):4553-60. PubMed ID: 17705359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores.
    Keith JM; Barbier AJ; Wilson SJ; Miller K; Boggs JD; Fraser IC; Mazur C; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5325-9. PubMed ID: 17765543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 4-Bromo-6-nitroquipazine: a new ligand for studying 5-hydroxytryptamine uptake sites in vivo.
    Hashimoto K; Goromaru T
    Neuropharmacology; 1992 Sep; 31(9):869-74. PubMed ID: 1436394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of the zebrafish serotonin transporter functionally links TM10 to the ligand binding site.
    Severinsen K; Sinning S; Müller HK; Wiborg O
    J Neurochem; 2008 Jun; 105(5):1794-805. PubMed ID: 18266934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analogues of the neuroprotective tripeptide Gly-Pro-Glu (GPE): synthesis and structure-activity relationships.
    Alonso De Diego SA; Muñoz P; González-Muñiz R; Herranz R; Martín-Martínez M; Cenarruzabeitia E; Frechilla D; Del Río J; Jimeno ML; García-López MT
    Bioorg Med Chem Lett; 2005 May; 15(9):2279-83. PubMed ID: 15837309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mass-spectrometric studies of new 6-nitroquipazines-serotonin transporter inhibitors.
    Witowska-Jarosz J; Jarończyk M; Mazurek AP; Sylte I; Bojarski AJ; Chilmonczyk Z; Jarosz M
    Anal Bioanal Chem; 2012 Jan; 402(1):537-41. PubMed ID: 21960253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of diphenylmethyl analogues and their affinity for the melanocortin-4 receptor and the serotonin transporter.
    Nozawa D; Okubo T; Ishii T; Chaki S; Okuyama S; Nakazato A
    Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):1044-50. PubMed ID: 17603198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
    Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
    Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity study.
    Glennon RA; Ismaiel AE; McCarthy BG; Peroutka SJ
    Eur J Pharmacol; 1989 Sep; 168(3):387-92. PubMed ID: 2583244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular interactions of buspirone analogues with the serotonin transporter.
    Jarończyk M; Chilmonczyk Z; Mazurek AP; Nowak G; Ravna AW; Kristiansen K; Sylte I
    Bioorg Med Chem; 2008 Oct; 16(20):9283-94. PubMed ID: 18812261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and biological effects of pure stereoisomeric novel soft anticholinergics.
    Tóth-Sarudy E; Tóth G; Pallagi I; Seres G; Vitális B; Tapfer M; Perczel V; Kurucz I; Bodor N; Zubovics Z
    Pharmazie; 2006 Feb; 61(2):90-6. PubMed ID: 16526553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding.
    Schenk S; Hely L; Lake B; Daniela E; Gittings D; Mash DC
    Eur J Neurosci; 2007 Dec; 26(11):3229-36. PubMed ID: 18005064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophore.
    Keith JM; Gomez LA; Letavic MA; Ly KS; Jablonowski JA; Seierstad M; Barbier AJ; Wilson SJ; Boggs JD; Fraser IC; Mazur C; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2007 Feb; 17(3):702-6. PubMed ID: 17107798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An extended study of dimeric phenyl tropanes.
    Nielsen S; Pedersen CM; Hansen SG; Petersen MD; Sinning S; Wiborg O; Jensen HH; Bols M
    Bioorg Med Chem; 2009 Jul; 17(14):4900-9. PubMed ID: 19560930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
    Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
    Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site.
    Zampieri D; Grazia Mamolo M; Laurini E; Zanette C; Florio C; Collina S; Rossi D; Azzolina O; Vio L
    Eur J Med Chem; 2009 Jan; 44(1):124-30. PubMed ID: 18440098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding.
    Sugimoto Y; Kajiwara Y; Hirano K; Yamada S; Tagawa N; Kobayashi Y; Hotta Y; Yamada J
    Eur J Pharmacol; 2008 Sep; 592(1-3):116-22. PubMed ID: 18655786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of 6beta-D-glucosyl and 6-nitroxy (-)-galanthamine derivatives as acetylcholinesterase inhibitors.
    Perissutti E; Fiorino F; Severino B; Frecentese F; Massarelli P; Nencini C; Santagada V; Caliendo G
    Pharmazie; 2007 Jun; 62(6):403-5. PubMed ID: 17663183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further studies on the binding of N1-substituted tryptamines at h5-HT6 receptors.
    Nyandege A; Kolanos R; Roth BL; Glennon RA
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1691-4. PubMed ID: 17239595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.